Not applicableUnknownNCT05083494
What this trial is testing
Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.
Who this might be right for
Cancer
Assistance Publique Hopitaux De Marseille 260